Rubius Therapeutics

Genetically modifying hematopoietic stem cells to create RBC therapeutics in metabolic deficiencies, autoimmune disorders, and cancer

placeCambridge, Massachusetts, United States calendar_todayFounded 2015 groups256 employees language rubiustx.com

Registered entities

Innovation

29 patent families (6 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 5,694 times.

YearFilings
20152
20163
20174
20187
201916
202016
202115
202214
20234

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital250%
Private equity125%
Other / undisclosed125%
Coming soon